title: Predictors and outcomes of acyclovir-resistant herpes simplex virus infection among hematopoietic cell transplant recipients: case-case-control investigation.
authors.affiliation: Division of Infectious Diseases, Detroit Medical Center, Wayne State University, Detroit, MI, USA.
authors.forename: Diixa
authors.initials: D
authors.lastname: Patel
authors.forename: Dror
authors.initials: D
authors.lastname: Marchaim
authors.forename: Gil
authors.initials: G
authors.lastname: Marcus
authors.forename: Ravi
authors.initials: R
authors.lastname: Gayathri
authors.forename: Paul R
authors.initials: PR
authors.lastname: Lephart
authors.forename: Tsillia
authors.initials: T
authors.lastname: Lazarovitch
authors.forename: Ronit
authors.initials: R
authors.lastname: Zaidenstein
authors.forename: Pranatharthi
authors.initials: P
authors.lastname: Chandrasekar
mesh_terms: D000212:Acyclovir / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D016022:Case-Control Studies; D024882:Drug Resistance, Viral; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology; D019337:Hematologic Neoplasms / Q000628:therapy* / Q000821:virology; D018380:Hematopoietic Stem Cell Transplantation; D006561:Herpes Simplex / Q000188:drug therapy / Q000821:virology*; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D018139:Simplexvirus / Q000187:drug effects / Q000302:isolation & purification*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D000212:Acyclovir